Cited by 295

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

The genetic basis of disease

Jackson, Maria, Marks, Leah, May, Gerhard H.W., Wilson, Joanna B.·2018·Essays in Biochemistry

Abstract

Genetics plays a role, to a greater or lesser extent, in all diseases. Variations in our DNA and differences in how that DNA functions (alone or in combinations), alongside the environment (which encompasses lifestyle), contribute to disease processes. This review explores the genetic basis of human disease, including single gene disorders, chromosomal imbalances, epigenetics, cancer and complex disorders, and considers how our understanding and technological advances can be applied to provision of appropriate diagnosis, management and therapy for patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1042/ebc20170053

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 6 references

Research works printed but not linked: 65

  1. Gonzaga-Jauregui, 2012, Human genome sequencing in health and disease, Annu. Rev. Med., 63, 35, 10.1146/annurev-med-051010-162644 · DOI
  2. Murphy, 2018, Forensic DNA typing, Annu. Rev. Criminol., 1, 497, 10.1146/annurev-criminol-032317-092127 · DOI
  3. Samuels, 2015, Genetic mosaics and the germline lineage, Genes (Basel), 6, 216, 10.3390/genes6020216 · DOI
  4. Griffiths, 2000, An Introduction to Genetic Analysis
  5. Bonora, 2017, Structural aspects of the inactive X chromosome, Phil. Trans. R. Soc. B Biol. Sci., 372, 20160357, 10.1098/rstb.2016.0357 · DOI
  6. Fiot, 2016, X-chromosome gene dosage as a determinant of impaired pre and postnatal growth and adult height in Turner syndrome, Eur. J. Endocrinol., 174, 281, 10.1530/EJE-15-1000 · DOI
  7. Gamble, 2012, Sex determination, Current Biol., 22:, 257, 10.1016/j.cub.2012.02.054 · DOI
  8. Gilbert, 2000, Developmental Biology
  9. Pinheiro, 2017, X chromosome inactivation: new players in the initiation of gene silencing, F1000 Res., 6, 344, 10.12688/f1000research.10707.1 · DOI
  10. Stevant, 2018, A brief history of sex determination, Mol. Cell. Endocrinol., 10.1016/j.mce.2018.04.004 · DOI
  11. Tanaka, 2014, Regulation of male sex determination: genital ridge formation and Sry activation in mice, Cell. Mol. Life Sci., 71, 4781, 10.1007/s00018-014-1703-3 · DOI
  12. Chial, 2008, Mendelian genetics: patterns of inheritance and single-gene disorders, Nat. Education, 1, 63
  13. Davis, 2001, Cystic fibrosis, Pediatr. Rev., 22, 257, 10.1542/pir.22-8-257 · DOI
  14. Martiniano, 2016, Cystic fibrosis: a model system for precision medicine, Curr. Opin. Pediatr., 28:, 312, 10.1097/MOP.0000000000000351 · DOI
  15. Ornitz, 2017, Achondroplasia: development, pathogenesis, and therapy, Dev. Dyn., 246, 291, 10.1002/dvdy.24479 · DOI
  16. Schmidt, 2016, Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives, Clin. Pharmacol., 8:, 127
  17. Chinnery, 2000, Mitochondrial Disorders Overview. SourceGeneReviews®, 1993
  18. Nightingale, 2016, Emerging therapies for mitochondrial disorders, Brain, 139, 1633, 10.1093/brain/aww081 · DOI
  19. Reznichenko, 2016, Mitochondrial transfer: implications for assisted reproductive technologies, Appl. Transl. Genom., 11, 40, 10.1016/j.atg.2016.10.001 · DOI
  20. Barlow, 2014, Genomic imprinting in mammals, Cold Spring Harb. Perspect. Biol., 6, a018382, 10.1101/cshperspect.a018382 · DOI
  21. Lobo, 2008, Genomic imprinting and patterns of disease inheritance, Nat. Education, 1, 66
  22. Schuebel, 2016, Making sense of epigenetics, Int. J. Neuropsychopharmacol., 19, 1, 10.1093/ijnp/pyw058 · DOI · Paper page
  23. Soshnev, 2016, Greater than the sum of parts: complexity of the dynamic epigenome, Mol. Cell, 62, 681, 10.1016/j.molcel.2016.05.004 · DOI
  24. Venturá-Junca, 2015, In vitro fertilization (IVF) in mammals: epigenetic and developmental alterations. Scientific and bioethical implications for IVF in humans, Biol. Res., 48:, 68, 10.1186/s40659-015-0059-y · DOI
  25. Zoghbi, 2016, Epigenetics and human disease, Cold Spring Harb. Perspect. Biol., 8:, a019497, 10.1101/cshperspect.a019497 · DOI
  26. Chial, 2008, Genome-wide association studies (GWAS) and obesity, Nat. Education, 1, 80
  27. Schulz, 2010, The Dutch Hunger Winter and the developmental origins of health and disease, Proc. Natl. Acad. Sci. U.S.A., 107, 16757, 10.1073/pnas.1012911107 · DOI · Paper page
  28. Aunan, 2017, The biology of aging and cancer: a brief overview of shared and divergent molecular hallmarks, Aging Dis., 8, 628, 10.14336/AD.2017.0103 · DOI
  29. Burotto, 2014, The MAPK pathway across different malignancies: A new perspective, Cancer, 120, 3446, 10.1002/cncr.28864 · DOI
  30. Delbridge, 2012, The role of the apoptotic machinery in tumor suppression, Cold Spring Harb. Perspect. Biol., 4, a008789, 10.1101/cshperspect.a008789 · DOI
  31. Feinberg, 2016, Epigenetic modulators, modifiers and mediators in cancer aetiology and progression, Nat. Rev. Genet., 17, 284, 10.1038/nrg.2016.13 · DOI · Paper page
  32. Fischer, 2017, Cell cycle transcription control: DREAM/MuvB and RB-E2F complexes, Crit. Rev. Biochem. Mol. Biol., 52, 638, 10.1080/10409238.2017.1360836 · DOI · Paper page
  33. Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 · DOI · Paper page
  34. Pereira, 2016, The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes, Nat. Commun., 7, 11479, 10.1038/ncomms11479 · DOI
  35. Ryana, 2016, The hallmarks of premalignant conditions: a molecular basis for cancer prevention, Semin. Oncol., 43, 22, 10.1053/j.seminoncol.2015.09.007 · DOI
  36. Sherr, 2004, Principles of tumor suppression, Cell, 116, 235, 10.1016/S0092-8674(03)01075-4 · DOI
  37. Weinberg, 2014, The Biology of Cancer
  38. Feero, 2014, Genomics, personalized medicine, and paediatrics, Acad. Pediatr., 14, 14, 10.1016/j.acap.2013.06.008 · DOI
  39. Genomics England, 2018, 100,000 genomes project
  40. Naidoo, 2011, Human genetics and genomics a decade after the release of the draft sequence of the human genome, Hum. Genomics, 5, 577, 10.1186/1479-7364-5-6-577 · DOI
  41. Rehm, 2017, Evolving healthcare through personal genomics, Nat. Rev. Genet., 18, 259, 10.1038/nrg.2016.162 · DOI
  42. Bishop, 2010, Applications of fluorescence in situ hybridization (FISH) in detecting genetic aberrations of medical significance, Biosci. Horiz., 3, 85, 10.1093/biohorizons/hzq009 · DOI
  43. Ferrie, 1992, Development, multiplexing, and applications of ARMS tests for common mutations in the CFTR gene, Am. J. Hum. Genet., 51, 251
  44. Frese, 2013, Next-generation sequencing: from understanding biology to personalized medicine, Biology (Basel), 2, 378
  45. Katsanis, 2013, Molecular genetic testing and the future of clinical genomics, Nat. Rev. Genet., 14, 415, 10.1038/nrg3493 · DOI
  46. Kchouk, 2017, Generations of sequencing technologies: from first to next generation, Biol. Med. (Aligarh), 9, 395, 10.4172/0974-8369.1000395 · DOI
  47. Norbury, 2006, DNA analysis: what and when to request?, Arch. Dis. Child., 91, 357, 10.1136/adc.2005.089219 · DOI
  48. O’Connor, 2008, Karyotyping for chromosomal abnormalities, Nat. Education, 1, 27
  49. O’Connor, 2008, Fluorescence in situ hybridization (FISH), Nat. Education, 1, 171
  50. Stuppia, 2012, Use of the MLPA assay in the molecular diagnosis of gene copy alterations in human genetic diseases, Int. J. Mol. Sci., 13, 3245, 10.3390/ijms13033245 · DOI
  51. Wiszniewska, 2014, Combined array CGH plus SNP genome analyses in a single assay for optimized clinical testing, Eur. J. Hum. Genet., 22, 79, 10.1038/ejhg.2013.77 · DOI
  52. Xuan, 2013, Next-generation sequencing in the clinic: promises and challenges, Cancer Lett., 340, 284, 10.1016/j.canlet.2012.11.025 · DOI
  53. Aronson, 2015, Building the foundation for genomics in precision medicine, Nature, 526, 336, 10.1038/nature15816 · DOI
  54. Chaterji, 2017, CRISPR genome engineering for human pluripotent stem cell research, Theranostics, 7, 4445, 10.7150/thno.18456 · DOI
  55. Eid, 2016, Genome editing: the road of CRISPR/Cas9 from bench to clinic, Exp. Mol. Med., 48, e265, 10.1038/emm.2016.111 · DOI
  56. Lockyer, 2016, The potential of CRISPR-Cas9 for treating genetic disorders, Biosci. Horiz., 9, 10.1093/biohorizons/hzw012 · DOI
  57. Martiniano, 2016, Cystic fibrosis: a model system for precision medicine, Curr. Opin. Pediatr., 28, 312, 10.1097/MOP.0000000000000351 · DOI
  58. Plönes, 2016, Molecular pathology and personalized medicine: the dawn of a new era in companion diagnostics–practical considerations about companion diagnostics for non-small-cell-lung-Cancer, J. Personal. Med., 6, 3, 10.3390/jpm6010003 · DOI
  59. Schmidt, 2016, Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives, Clin. Pharmacol., 8, 127
  60. Schneller, 2017, Genome editing for inborn errors of metabolism: advancing towards the clinic, BMC Medicine, 15, 43, 10.1186/s12916-017-0798-4 · DOI
  61. Sumaily, 2017, Phenylketonuria: a new look at an old topic, advances in laboratory diagnosis, and therapeutic strategies, Int. J. Health Sci., 11, 63
  62. Blashki, 2014, Genetics in general practice, Aust. Fam. Phys., 43, 428
  63. Harris, 2013, Counseling customers: emerging roles for genetic counselors in the direct-to-consumer genetic testing market, J. Genet. Couns., 22, 277, 10.1007/s10897-012-9548-0 · DOI
  64. Roberts, 2014, Emerging issues in public health genomics, Annu. Rev. Genomics Hum. Genet., 15, 461, 10.1146/annurev-genom-090413-025514 · DOI
  65. Su, 2013, Direct-to-consumer genetic testing: a comprehensive view, Yale J. Biol. Med., 86, 359

Cited by

Sorted by citations

See all 295

Metadata

Authors
Jackson, M., Marks, L., May, G. H. W., & Wilson, J. B.
Affiliations
  • School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, U.K.
  • School of Life Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, U.K.
Venue
Essays in Biochemistry
Published
2018-12-03
Volume
62
Issue
5
Pages
643-723
ISSN
  • 0071-1365
  • 1744-1358
Cited by
295
References
6
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review